Chronic Bronchitis Clinical Trials

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview Study Flyer

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview

If you’re a current or former smoker with COPD (also known as emphysema or chronic bronchitis), you know how challenging this disease can be. Peninsula Research Associates is conducting a new, no-cost clinical research study testing an investigational study medication for COPD. By participating, you’ll receive at no cost: Study-related ...

If you are a current or former smoker and experience symptoms from COPD (also known as emphysema or chronic bronchitis) such as wheezing, coughing, breathlessness or chest tightness, you may qualify for one of our paid research studies.

A research study is currently underway to investigate the effectiveness of an investigational product in the reduction of the annual rate of COPD Exacerbations.

A clinical research study near your home is testing a study medication. If you or a loved one has COPD, you may have an opportunity to volunteer and become part of this important study.

If you or a loved one has Chronic Obstructive Pulmonary Disease (COPD), you may be interested in this clinical research study. This study is testing the benefits of an investigational drug in reducing lung and heart complications in people with COPD.

Montana Medical Research is now enrolling a Clinical Research Trial for Chronic Obstructive Pulmonary Disease.

Doctors are now enrolling a Clinical Research tral for Chronic Obstructive Pulmonary Disease. You may qualify to take part in a clinical research study of an investigational medication if: You are 40-80 years of age Have a smoking history of 10 years or more Qualified participants will receive: Study related ...

If you are a curent or former smoker with chronic cough or shortness of breath you may have Chronic Obstructive Pulmonary Disease which includes chronic bronchitis and emphysema Local COPD Research Study Doctors are conducting a clinical research study of an investigational medication for COPD If you have been diagnosed ...